Miricorlilant
CORT118335-877
Phase 2 small_molecule completed
Quick answer
Miricorlilant for Antipsychotic-induced Weight Gain (AIWG) is a Phase 2 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CORCEPT THERAPEUTICS INC
- Indication
- Antipsychotic-induced Weight Gain (AIWG)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed